These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 37805074)

  • 1. Revisiting the Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals.
    Burns MJ; Ponting DJ; Foster RS; Thornton BP; Romero NE; Smith GF; Ashworth IW; Teasdale A; Simon S; Schlingemann J
    J Pharm Sci; 2023 Dec; 112(12):3005-3011. PubMed ID: 37805074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Landscape of Potential Small and Drug Substance Related Nitrosamines in Pharmaceuticals.
    Schlingemann J; Burns MJ; Ponting DJ; Martins Avila C; Romero NE; Jaywant MA; Smith GF; Ashworth IW; Simon S; Saal C; Wilk A
    J Pharm Sci; 2023 May; 112(5):1287-1304. PubMed ID: 36402198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining recommended acceptable intake limits for N-nitrosamine impurities in pharmaceuticals: Development and application of the Carcinogenic Potency Categorization Approach (CPCA).
    Kruhlak NL; Schmidt M; Froetschl R; Graber S; Haas B; Horne I; Horne S; King ST; Koval IA; Kumaran G; Langenkamp A; McGovern TJ; Peryea T; Sanh A; Siqueira Ferreira A; van Aerts L; Vespa A; Whomsley R
    Regul Toxicol Pharmacol; 2024 Jun; 150():105640. PubMed ID: 38754805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-Nitrosamine Formation in Pharmaceutical Solid Drug Products: Experimental Observations.
    Moser J; Ashworth IW; Harris L; Hillier MC; Nanda KK; Scrivens G
    J Pharm Sci; 2023 May; 112(5):1255-1267. PubMed ID: 36736774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitrosamine Impurities in Pharmaceuticals: An Empirical Review of their Detection, Mechanisms, and Regulatory Approaches.
    Bhirud D; Agrawal G; Shah H; Patel A; Palkar MB; Bhattacharya S; Prajapati BG
    Curr Top Med Chem; 2024; 24(6):503-522. PubMed ID: 38321910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantum Mechanical Assessment of Nitrosamine Potency.
    De S; Thapa B; Sayyed FB; Frank SA; Cornwell PD; Jolly RA
    Chem Res Toxicol; 2024 Jun; 37(6):1011-1022. PubMed ID: 38804898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modified NAP test: A simple and Responsive Nitrosating Methodology for Risk Evaluation of NDSRIs.
    Sharma N; Patel R; Bothara T; Jain S; Shah RP
    J Pharm Sci; 2023 May; 112(5):1333-1340. PubMed ID: 36871894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Nitrosamine drug substance related impurities (NDSRIs) - A proposal for the addition of subcategories to carcinogenic potency categorization approach categories 1 and 2 for NDSRIs with a molecular weight > 200 Da.
    Bercu J; Dirat O; Dobo K; Jolly R; Kenyon M; Harvey J; Nudelman R; Smith G; Trejo-Martin A; Urquhart M
    Regul Toxicol Pharmacol; 2024 Dec; 154():105704. PubMed ID: 39326488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for Assessing Acceptable Intakes for Novel
    Ponting DJ; Dobo KL; Kenyon MO; Kalgutkar AS
    J Med Chem; 2022 Dec; 65(23):15584-15607. PubMed ID: 36441966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine.
    Jolly RA; Cornwell PD; Noteboom J; Sayyed FB; Thapa B; Buckley LA
    Regul Toxicol Pharmacol; 2024 Sep; 152():105672. PubMed ID: 38968965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METASTATIC NODULAR MELANOMA DEVELOPING ON NEVUS SPILUS DURING INTAKE OF BETA BLOCKERS (BISOPROLOL/NEBIVOLOL) AND ACE INHIBITORS (PERINDOPRIL). POTENTIAL LINKS TО THE DRUG RELATED NITROSOGENESIS/CARCINOGENESIS, DUNNING-KRUGER EFFECT AND GENETIC WEAPONS OF THE NEW GENERATION.
    Tchernev G
    Georgian Med News; 2023 Oct; (343):172-178. PubMed ID: 38096536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic impurities in pharmaceuticals: A critical assessment of the cohort of concern with a focus on N-nitrosamines.
    Snodin DJ
    Regul Toxicol Pharmacol; 2023 Jun; 141():105403. PubMed ID: 37116739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity evaluation of a valsartan-related complex N-nitroso-impurity.
    Glowienke S; Onken U; Elhajouji A; Muthusamy S; Sangana R; Martus HJ; Bedman T; Hartmann A
    Regul Toxicol Pharmacol; 2022 Oct; 134():105245. PubMed ID: 35988810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical and Science-Based Strategy for Establishing Acceptable Intakes for Drug Product
    Dobo KL; Kenyon MO; Dirat O; Engel M; Fleetwood A; Martin M; Mattano S; Musso A; McWilliams JC; Papanikolaou A; Parris P; Whritenour J; Yu S; Kalgutkar AS
    Chem Res Toxicol; 2022 Mar; 35(3):475-489. PubMed ID: 35212515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of amine structural characteristics on N-nitrosamine formation potential relevant to postcombustion CO2 capture systems.
    Dai N; Mitch WA
    Environ Sci Technol; 2013 Nov; 47(22):13175-83. PubMed ID: 24138561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An update on the current status and prospects of nitrosation pathways and possible root causes of nitrosamine formation in various pharmaceuticals.
    Wichitnithad W; Nantaphol S; Noppakhunsomboon K; Rojsitthisak P
    Saudi Pharm J; 2023 Feb; 31(2):295-311. PubMed ID: 36942272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrosamine acceptable intakes should consider variation in molecular weight: The implication of stoichiometric DNA damage.
    Fine J; Allain L; Schlingemann J; Ponting DJ; Thomas R; Johnson GE
    Regul Toxicol Pharmacol; 2023 Dec; 145():105505. PubMed ID: 37805106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of nitrosamine and nitramine formation from NOx reactions with amines during amine-based carbon dioxide capture for postcombustion carbon sequestration.
    Dai N; Shah AD; Hu L; Plewa MJ; McKague B; Mitch WA
    Environ Sci Technol; 2012 Sep; 46(17):9793-801. PubMed ID: 22831707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of N-nitrosamines by micelle-catalysed nitrosation of aliphatic secondary amines.
    Breider F; Salihu I; von Gunten U
    Environ Sci Process Impacts; 2018 Oct; 20(10):1479-1487. PubMed ID: 30252010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific and total N-nitrosamines formation potentials of nitrogenous micropollutants during chloramination.
    Piazzoli A; Breider F; Aquillon CG; Antonelli M; von Gunten U
    Water Res; 2018 May; 135():311-321. PubMed ID: 29524858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.